sameAs
Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartmentsContact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148CCM1 regulates vascular-lumen organization by inducing endothelial polarityGas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosisVE-cadherin regulates endothelial actin activating Rac and increasing membrane association of TiamA novel endothelial-specific membrane protein is a marker of cell-cell contactsThe conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragilityFunctionally specialized junctions between endothelial cells of lymphatic vesselsJunctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigrationDifferential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localizationThe alternative splicing factor Nova2 regulates vascular development and lumen formation.Ve-ptp modulates vascular integrity by promoting adherens junction maturationGlycolytic regulation of cell rearrangement in angiogenesis.Stable vascular connections and remodeling require full expression of VE-cadherin in zebrafish embryos.Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludinAssociation of junctional adhesion molecule with calcium/calmodulin-dependent serine protein kinase (CASK/LIN-2) in human epithelial caco-2 cellsTargeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesisIdentification and characterisation of human Junctional Adhesion Molecule (JAM)Vascular endothelial growth factor induces SHC association with vascular endothelial cadherin: a potential feedback mechanism to control vascular endothelial growth factor receptor-2 signalingA monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeabilityVE-cadherin and desmoplakin are assembled into dermal microvascular endothelial intercellular junctions: a pivotal role for plakoglobin in the recruitment of desmoplakin to intercellular junctionsFunctional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherinVE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassemblyDynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cellsSox18 induces development of the lymphatic vasculature in miceContribution of JAM-1 to epithelial differentiation and tight-junction biogenesis in the mouse preimplantation embryoWnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitroSox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in miceUnique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel diseaseThe molecular basis of vascular lumen formation in the developing mouse aortaThe Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signalingVE-cadherin is a critical endothelial regulator of TGF-beta signallingTranscription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin.KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury.VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formationSox17 is indispensable for acquisition and maintenance of arterial identityHeterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.An EMMPRIN-γ-catenin-Nm23 complex drives ATP production and actomyosin contractility at endothelial junctionsIncrease in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy.
P50
Q24299236-A999A7B9-78F7-47B6-8FC3-A7979E499CF4Q24303092-AC62E659-1D36-4EF1-A162-23BFE2CD03A9Q24304408-68327499-3A2F-4FD8-88DC-6A66AA94533DQ24329055-3C07CFE5-A708-4473-B53F-0147CBF6E96CQ24515256-32E79C12-EE1A-4C63-975A-9D1341CC19B1Q24642987-7FDC5B64-E523-4615-9BFC-014C867C2EA6Q24675378-0A3B4AE5-ADAC-4B62-B89C-1A6C93394DA4Q24676415-1AF369E0-7B24-4973-8A90-BF5D3922FF8DQ24682572-F9635C36-8384-4936-AC4C-E9B8F49203BBQ24683420-FBA4B433-F15D-4642-86EA-14FB468FCC41Q27321847-3D7C85B9-8B19-480F-9870-4D173450CC07Q27332101-BA4FD571-FB2A-4975-85E2-03D9B4B2BBCDQ27335102-35BB4FAC-91B2-4D2A-9F8B-7CB5A42D4C4FQ27348907-4AA9CC67-1920-4E00-9EE0-65D242C1D02BQ28139702-430DBAF6-740A-4E97-BD1D-1EAA09BFFA65Q28140550-A5E03CDC-C55B-4808-AC96-D58CF6A0C5B4Q28140788-300D63C0-0B9C-48C5-9FCE-3EF250BCDA8DQ28145696-EBC2099E-EBB4-40FE-98A8-A2DE1FF4700DQ28214542-2238A82B-C0B4-49B6-8D85-6B3F6EEBBB89Q28215378-1D5C9872-0442-4206-90A7-60CB3D20F11DQ28282651-90327E2F-A17A-434D-A060-58D7766F80FFQ28294723-2D6AFBC7-7C9C-4FD7-B2E2-410BBC4BDE62Q28298669-F6184979-6BEE-4C5B-A988-37CE1F837983Q28353893-AF4BF889-A900-4097-B40B-6540A9E0ADDAQ28505137-B7725A2F-376B-4100-8078-64A3D410C716Q28508091-07ABAF03-1ECE-4541-A04F-7BDD69D64CF4Q28535094-68750E4E-9F14-4435-BD78-ECC4F3886A58Q28586129-E95D9331-5323-44FF-8F95-4F27FC930728Q28586834-CA641B85-F39B-41EF-91ED-5E3C45A2EA71Q28593452-3B7087D7-0875-4A65-85AE-7711FBDD185BQ28594566-3AC54657-7B1F-4904-A9C3-70107A7693D1Q28594650-919AEEC9-797D-4FC8-9E25-D5DD5245CA3BQ28771711-71207F27-7802-4660-8EE5-7EFEC0B04E00Q30278010-1A95625B-9280-47A3-AF1E-35E7D2BF6B32Q30476048-F50C933A-8B55-4A64-AE77-D014E4F86C3EQ30539522-42ACDA34-48D9-450C-863B-8A70476B3503Q30557264-372AA251-ADB4-4956-B61E-E828A4B7FD5CQ30579125-5EC0BB14-33F8-4BA7-B9ED-644C577ED0A8Q30586673-EE00942D-A99E-4DCC-93CE-69296E3AA062Q33250463-353BFB6E-E103-4883-89F7-5B67C1C83C28
P50
description
Italiaans onderzoekster
@nl
researcher ORCID ID = 0000-0002-0007-0426
@en
name
Elisabetta Dejana
@ast
Elisabetta Dejana
@ca
Elisabetta Dejana
@en
Elisabetta Dejana
@es
Elisabetta Dejana
@fr
Elisabetta Dejana
@ga
Elisabetta Dejana
@nl
Elisabetta Dejana
@sl
Elisabetta Dejana
@sq
type
label
Elisabetta Dejana
@ast
Elisabetta Dejana
@ca
Elisabetta Dejana
@en
Elisabetta Dejana
@es
Elisabetta Dejana
@fr
Elisabetta Dejana
@ga
Elisabetta Dejana
@nl
Elisabetta Dejana
@sl
Elisabetta Dejana
@sq
altLabel
ELISABETTA DEJANA
@en
prefLabel
Elisabetta Dejana
@ast
Elisabetta Dejana
@ca
Elisabetta Dejana
@en
Elisabetta Dejana
@es
Elisabetta Dejana
@fr
Elisabetta Dejana
@ga
Elisabetta Dejana
@nl
Elisabetta Dejana
@sl
Elisabetta Dejana
@sq
P108
P1006
P214
P244
P1006
P108
P19
P1960
D5F9HHIAAAAJ
P21
P213
0000 0000 3328 3378
P214
P244
P27
P31
P3762
P496
0000-0002-0007-0426
P5463
Dejana_Elisabetta
P569
1951-11-21T00:00:00Z